| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/17/2007 | EP1311289B1 Vaccines containing ribavirin |
| 10/17/2007 | EP1303291B1 Anti-hiv and anti-tumor peptides and fragments of lysozyme |
| 10/17/2007 | EP1153034B1 Growth hormone secretagogues |
| 10/17/2007 | EP1144006B1 CCR5 Antibody PA14 |
| 10/17/2007 | EP1123387B1 Mn gene and protein |
| 10/17/2007 | EP1093818B9 Powdery preparation for mucosal administration containing polymeric medicine |
| 10/17/2007 | EP1092018B1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 10/17/2007 | EP1088088B1 Diacylglycerol o-acyltransferase |
| 10/17/2007 | EP1076710B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 10/17/2007 | EP0993613B8 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma |
| 10/17/2007 | EP0970195B1 Fatty-acid amide hydrolase |
| 10/17/2007 | CN101056890A Deamidated interferon-beta |
| 10/17/2007 | CN101056886A Molecules which promote hematopoiesis |
| 10/17/2007 | CN101056652A Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
| 10/17/2007 | CN101056651A Method of enhancing the immune response to a vaccine |
| 10/17/2007 | CN101056650A Stable formulations of insulinoptropic peptides |
| 10/17/2007 | CN101056649A Growth factor treatment for asthma |
| 10/17/2007 | CN101056648A Application of [d-meala]3- [etval]4 cyclosporin in treating hepatitis c infection and medicine composition containing [d-meala]3- [etval]4 cyclosporin |
| 10/17/2007 | CN101056647A Vasoactive intestinal polypeptide pharmaceuticals |
| 10/17/2007 | CN101056613A Controlled and directed local delivery of anti-inflammatory compositions |
| 10/17/2007 | CN101054419A Vectors with modified protease-dependent tropism |
| 10/17/2007 | CN101054418A Fusion polypeptide and application thereof in preparing scald medicament |
| 10/17/2007 | CN101054414A Method of extracting and preparing deer DGF |
| 10/17/2007 | CN101054413A Tumor correlated albumen, coding gene and application thereof |
| 10/17/2007 | CN101054412A Pathogenic gene for far end arthrosis bend, detection method and application thereof |
| 10/17/2007 | CN101054409A Amphiphilic short peptide and use thereof |
| 10/17/2007 | CN101054408A Method for separating housefly secretion type antibacterial peptide, product and application thereof |
| 10/17/2007 | CN101053660A Protein and peptide medicine carrier and its preparation method and application |
| 10/17/2007 | CN101053657A External applied preparations for treating intractable skin ulcer |
| 10/17/2007 | CN101053573A Compositions and methods based on VEGF antisense oligonucleotides |
| 10/17/2007 | CN101053561A Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis |
| 10/17/2007 | CN100343393C Central airway administration for systemic delivery of therapeutics |
| 10/17/2007 | CN100343282C Hybrid interferon compositions and methods of use |
| 10/17/2007 | CN100343276C Bone formation stimulant, synthetic method and uses thereof |
| 10/17/2007 | CN100342910C Insulin dripping pills and its preparation process |
| 10/17/2007 | CN100342909C Thymosin alpha-1 aqua prepn and its prepn process and application |
| 10/17/2007 | CN100342908C Pharmaceutical form of administration for peptides, method for its production and use |
| 10/17/2007 | CN100342907C Treatment of aspergillus infections with thymosin alpha 1 |
| 10/17/2007 | CN100342906C Use of polyproline polypeptide in preparing medicine for treating malignant tumour |
| 10/16/2007 | USRE39887 A cyclic depsipeptide from a tunicate of the Ascidiacea class; viricides, antitumor agents, immunosuppressants and cytotoxic agents |
| 10/16/2007 | US7282625 Using plants as bioreactors for biosynthesis of functional antibodies |
| 10/16/2007 | US7282580 Protein molecule useful for inhibition of anthrax toxin |
| 10/16/2007 | US7282578 Having at least one intron sequence; constructs and host cells; expression product and antibodies obtainable by immunization of an animal therewith, as well as the use of antibodies in screening methods for the identification of tumors |
| 10/16/2007 | US7282577 Nucleotide sequences coding hemolytic protein for use tool in treatment of jelly fish stings |
| 10/16/2007 | US7282576 Coactivators in the diagnosis and treatment of breast cancer |
| 10/16/2007 | US7282572 Method and device for improving protein stability and solubility |
| 10/16/2007 | US7282571 Concentrating a pyrene actin; mixing the concentrated pyrene actin with sucrose, a stabilizing agent, and a reducing agent, rapidly freezing |
| 10/16/2007 | US7282564 RNA interference pathway genes as tools for targeted genetic interference |
| 10/16/2007 | US7282560 PRO 4326 polypeptides |
| 10/16/2007 | US7282559 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
| 10/16/2007 | US7282558 PRO4329 polypeptide |
| 10/16/2007 | US7282556 Polynucleotides and polypeptides relating to the modulation of SIRPα-CD47 |
| 10/16/2007 | US7282510 neurotrophic N-glyoxyl-prolyl ester compounds e.g. (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylic acid; non-immunosuppressive; side effect reduction; neurodegenerative diseases |
| 10/16/2007 | US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics |
| 10/16/2007 | US7282491 inhibiting proteasomal activity in a pathogen under conditions effective to make the pathogen susceptible to antibacterial host defenses, thereby treating the pathogen infection |
| 10/16/2007 | US7282489 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia |
| 10/16/2007 | US7282488 Introducing a nucleic acid encoding an agent that increases activated protein C; expressing the agent in the cells; and increasing the APC sufficient to treat the blood vessel. |
| 10/16/2007 | US7282484 Oral administration of an amino acid with a N-terminal blocking group and a N-(2-boric pyrrolyl) group attached to the carboxyl group; anticarcinogenic, antiproliferative, antimetastasis agents for lung, kidney, pancreatic, breast, and colorectal cancers; angiogenesis inhibition |
| 10/16/2007 | US7282483 Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF |
| 10/16/2007 | US7282482 NGF for the prevention of demyelination in the nervous system |
| 10/16/2007 | US7282481 Improved thermostability, acid resistance, alkali resistance, resistance to proteolytic enzymes, and DNA synthesis promoting activity |
| 10/16/2007 | US7282480 Aqueous sustained-release formulations of proteins |
| 10/16/2007 | US7282479 or a vector into which a cytokine gene is integrated so that cytokine can be expressed in the malignant tumor cell; particle surfaces may be bound to an antibody which selectively binds to malignant tumor cells. |
| 10/16/2007 | US7282477 Administering Cycstatin C homologues to inhibit transforming growth factor-beta stimulation of epithelial-mesenchymal transitions (EMT); antineoplastic agents |
| 10/16/2007 | US7282476 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 10/16/2007 | US7282368 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 10/16/2007 | US7282365 Isolated nucleic acid molecule; enhancing immunity to the protein product expressed by the HER2/neu tumor-associated antigen |
| 10/16/2007 | US7282352 Substituting the endogenous signal peptide of a subunit of FSH with an amino acid sequence comprising the signal peptide of human growth hormone (hGH). |
| 10/16/2007 | US7282344 Also mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the method; high throughput drug screening |
| 10/16/2007 | US7282222 Methods and compositions for directing cells to target organs |
| 10/16/2007 | US7282219 Medicine of high molecular weight such as insulin and a cationic polymer such as aminoalkyl methacrylate copolymer, the preparation further comprising at least one kind of basic amino acid or salt |
| 10/16/2007 | US7282216 Prepared by blending hydrophobic biocompatible, biodegradable polymers or copolymers, such as poly(lactide-co-glycolide), and a biocompatible, amphipathic copolymer having a water absorption ratio of 2 or less; sustained release drug delivery |
| 10/16/2007 | US7282214 Biomedical devices with antimicrobial coatings |
| 10/16/2007 | US7282209 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders |
| 10/16/2007 | US7282208 Method for stimulating wound healing |
| 10/16/2007 | US7282207 Multimeric polypeptide antigen; uterine cancer |
| 10/16/2007 | US7282206 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 10/16/2007 | US7282204 modulating tumor growth by contacting a tumor cell with an agonist or antagonist of IL-23, particularly a binding mixture of IL-23R or nucleotide coding it comprising: an antigen-binding site of an antibody; an extracellular region of IL-23R; a small molecule; and an anti-sense nucleic acid or siRNA |
| 10/16/2007 | US7282202 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease |
| 10/16/2007 | US7282201 Methods of promoting the growth or differentiation of hematopoietic stem or progenitor cells by non-muscle type cofilin |
| 10/16/2007 | US7282200 Composition of fibroblast or chondrocyte cells transfected or transduced with a gene encoding transforming growth factor beta 1 (TGF- beta 1) or bone morphogenetic protein 2 (BMP-2), and chondrocyte cells that have not been transfected with the gene; generating hyaline cartilage at a target site |
| 10/16/2007 | US7282198 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
| 10/16/2007 | US7281641 Stackable low depth tray |
| 10/16/2007 | CA2159609C Factor xiii for treatment of skin wounds |
| 10/16/2007 | CA2131904C Reconstituted cartilage tissue |
| 10/16/2007 | CA2124126C Monoclonal antibodies and fv specific for cd2 antigen |
| 10/16/2007 | CA2114250C Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases |
| 10/14/2007 | CA2582784A1 Methods and products for enhancing energy and nutrition in human beings |
| 10/13/2007 | CA2566832A1 Cyclised alpha-conotoxin peptides |
| 10/11/2007 | WO2007115261A2 Drug delivery methods, structures, and compositions for nasolacrimal system |
| 10/11/2007 | WO2007115259A2 Nasolacrimal drainage system implants for drug therapy |
| 10/11/2007 | WO2007115143A2 Dead spindle pto with compliant grounding mechanism |
| 10/11/2007 | WO2007115135A2 Aircraft passenger seat |
| 10/11/2007 | WO2007114881A1 Technology for preparation of macromolecular microspheres |
| 10/11/2007 | WO2007114838A1 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 10/11/2007 | WO2007114697A1 Novel composition for tumor growth control |
| 10/11/2007 | WO2007113682A2 Tgf-beta pharmaceutical compositions |
| 10/11/2007 | WO2007113665A2 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides |
| 10/11/2007 | WO2007113633A2 Immunogenic compositions comprising cat allergen fel dl |
| 10/11/2007 | WO2007113540A2 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle |